Michael Seth Altman

Companies

• ARYA Sciences Acquisition Corp IVBoard member Feb 25, 2021 to Jul 31, 2024¹
• ARYA Sciences Acquisition Corp IVChief financial officer Feb 25, 2021 to Jul 31, 2024¹
• Nautilus Biotechnology, Inc.Board member Aug 6, 2020 to Jun 17, 2024²
• Lyra Therapeutics, Inc.Board member Apr 30, 2020 to Jun 14, 2024³
• Freenome, Inc.Board member Jun 11, 2024 to Jun 13, 2024⁴
• Freenome, Inc.Chief Business Officer Jun 11, 2024 to Jun 13, 2024⁴
• ARYA Sciences Acquisition Corp VBoard member Jul 12, 2021 to Jul 15, 2021⁵
• ARYA Sciences Acquisition Corp VChief financial officer Jul 12, 2021 to Jul 15, 2021⁵
• Nautilus Biotechnology, Inc.Chief financial officer Aug 6, 2020 to Aug 11, 2020²
• Cerevel Therapeutics Holdings, Inc.Board member Jun 4, 2020 to Jun 9, 2020⁶
• Cerevel Therapeutics Holdings, Inc.Chief financial officer Jun 4, 2020 to Jun 9, 2020⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FFreenome, Inc. FRNM2,352,500 shares⁷$28.9M at $12.29Jul 20, 2026
• ASARYA Sciences Acquisition Corp IV0 shares⁸Jul 31, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 20, 2026Converted 2,066,250 shares of Freenome, Inc.⁷
• Jul 31, 2024Returned to company 499,000 shares of ARYA Sciences Acquisition Corp IV⁸
• Jun 13, 2024Granted 286,250 shares at $10.00 of Freenome, Inc.⁹